Morén et al. demonstrated that LXRα activation suppressed TGFβ-induced differentiation of cancer-associated fibroblasts by repressing the promoter activity of ACAT2, resulting in limiting HCC growth [54]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.